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INTRODUCTION:  Renal  cell carcinoma  (RCC)  accounts  for approximately  3% of adult malignancies  and  is
responsible  for  over  13,000  deaths  in the  U.S.  annually.  The  fatalities  are  largely  due to  distant  metastasis,
with  lung,  liver,  bone  and  brain  being  most  commonly  affected  organs.  Gastric  metastasis  from  RCC  is  a
rare event  (less  than  20 cases  reported  in  the  English  language  literature)  and usually  presents  as a  large,
solitary  mass  or ulcer  (average  size  of  4.8  cm)  resembling  primary  gastric  cancer.  Here we report  the  ﬁrst
case  of metastatic  RCC  presenting  as  small  gastric  polyps.
PRESENTATION  OF  CASE:  The  patient  was  a 60-year-old  African  American  woman  with  a history  of
clear  cell  RCC  (pT1bNX).  She  underwent  esophagogastroduodenoscopy  and  colonoscopy  5  months  after
nephrectomy  due  to anemia.  Two  non-ulcerated,  0.6-cm  benign-appearing  polyps  were found  at  the
greater  curvature  of  the  gastric  body,  which  were  subsequently  removed  endoscopically.  Unexpectedly,
histopathologic  examination  of  the  gastric  polyps  revealed  nested  collections  of vacuolated  epithe-
lioid  cells  in  a background  of delicate,  arborizing  vasculature,  immediately  beneath  the  congested  and
hyperplastic  foveolar  epithelium.  A  diagnosis  of  metastatic  RCC  was  rendered  after  conﬁrming  the  renal
epithelial  origin  by immunohistochemical  stains.
DISCUSSION:  Gastric  metastasis  from  RCC  usually  presents  as a large,  solitary  mass  or  ulcer,  but it can  be
subtle and  present  as  multiple,  small  benign-appearing  polyps.
CONCLUSION:  A  careful  follow  up  and  thorough  endoscopic  and  histopathologic  examinations  should  be
conducted  in patients  with  a  history  of  RCC  who  present  with  gastrointestinal  manifestations.
ical A© 2012 Surg
. Introduction
Renal cell carcinoma (RCC) accounts for approximately 3% of
dult malignancies. The age-adjusted incidence of RCC has been
ncreasing for the past 30 years in the United States and most
uropean countries.1 More than 50% of RCCs are now detected
ncidentally and approximately one third of the patients have
etastasis at the time of initial diagnosis.2 RCC is responsible for
ver 13,000 deaths in the United States annually,3 largely due to
istant metastasis. Metastatic RCCs may  occur in virtually all organ
ystems. The usual sites of metastasis include lung (75%), soft tis-
ue (36%), bone (20%), liver (18%), cutaneous sites (8%), and central
ervous system (8%).4 Gastric metastasis from RCC is extremely
are, with only 19 cases reported in the English language literature.
ndoscopically, the gastric metastasis from RCC usually presents as
 large, solitary mass or ulcer (average size of 4.8 cm)  resembling
∗ Corresponding author at: Department of Pathology, North Pavillion 3542, 1802
th Avenue South, Birmingham, AL 35249-7331, USA. Tel.: +1 205 975 8880;
ax:  +1 205 975 5242.
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primary gastric cancer. Here we  report the ﬁrst case of metastatic
RCC presenting as multiple, small, benign-appearing gastric polyps.
2. Presentation of case
The patient, a 60-year-old African American woman, had a
history of tobacco smoking, anemia, and chronic kidney disease sec-
ondary to hypertension. She underwent evaluation for increased
renal insufﬁciency by ultrasound in July 2010. A large, solid,
hypervascular mass was  identiﬁed in the right kidney, which was
conﬁrmed by subsequent Magnetic Resonance Imaging (MRI). The
patient underwent a laparoscopic radical nephrectomy in August
2010. On gross examination, a 6.4 cm × 5.1 cm × 3.5 cm,  well cir-
cumscribed mass was identiﬁed near the upper pole of the kidney,
distending the renal capsule. The cut surface of the lesion had
a heterogeneous, golden yellow to tan appearance. Histological
examination revealed a clear cell RCC, Fuhrman nuclear grade I/IV.
The tumor was limited to the kidney. No lymph nodes were identi-
ﬁed. The pathologic stage was pT1bNX. The patient’s post-operative
Open access under CC BY-NC-ND license.course was uneventful and she did not receive any neoadjuvant
chemotherapy or immunotherapy.
In January 2011, the patient underwent esophagogastroduo-
denoscopy and colonoscopy due to iron deﬁciency anemia. The
BY-NC-ND license.
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Fig. 1. Endoscopic ﬁndings. Two non-ulcerated polyps with central indentation were found at the greater curvature of the gastric body, each measuring 6 mm in greatest
d
p
s
c
d
n
a
w
t
e
t
e
a
e
u
m
F
a
simension (A and B).
atient had no previous history of gastrointestinal disease. Two
imilar, non-ulcerated polyps were found arising from the greater
urvature of the gastric body, each measuring 6 mm  at the greatest
imension, which were completely removed (Fig. 1). The duode-
um appeared unremarkable. Colonoscopy revealed two  polyps
rising from ascending and transverse colon, respectively, which
ere subsequently biopsied. Histologic examination of the gas-
ric polyps revealed nodular and nested collections of vacuolated
pithelioid cells interspersed with delicate, arborizing vascula-
ure, immediately beneath the congested and hyperplastic foveolar
pithelium. The lesions were conﬁned to the lamina propria, with
n inﬁltrative growth pattern at the periphery. The cells of interest
xhibited clear cytoplasm, round to ovoid nuclei with ﬁnely gran-
lar open chromatin and small, inconspicuous nucleoli. Occasional
itotic ﬁgures, including atypical forms, were also noted. The
ig. 2. Histologic characteristics of the gastric polyps. Submucosal nodular collection of ep
 nested growth pattern, in a background of delicate, arborizing vasculature (B, H&E, or
pectrum cytokeratin (2B inset), and diffusely expressed vimentin (2C, original magniﬁcalesional cells were immunoreactive with antibodies raised against
vimentin and paired box protein PAX-2, and focally with broad
spectrum cytokeratin (Fig. 2). The histomorphologic features and
the immunophenotype resulted in a diagnosis of metastatic RCC.
In addition, microscopic examination of colonic polyps revealed a
tubular adenoma and a hyperplastic polyp. In February 2011, she
was found to have multiple metastases in the lungs, bones, and
right nephrectomy bed, and received 2 cycles of oral Sunitinib, a
multi-targeted receptor tyrosine kinase inhibitor. She subsequently
presented with headache, nausea, vomiting, blurry vision and dizzi-
ness, and was  found to have a large metastasis in the left cerebellum
for which she underwent surgical resection. In August 2011, the
patient was started on Sorafenib, an inhibitor of several tyrosine
protein kinases and Raf kinases. Due to multi-organ metastases,
she expired 14 months after the initial diagnosis of RCC.
ithelioid clear cells (A, H&E, original magniﬁcation 40×). The lesional cell exhibited
iginal magniﬁcation 200×). Tumor cells were focally immunoreactive with broad
tion 200×) and PAX-2 (2D, original magniﬁcation 200×).
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3. Discussion
Metastasis to the stomach is an uncommon event, with carci-
nomas of lung and breast and malignant melanoma being the most
common origins.1 On the other hand, while metastatic RCC may
involve any organ system including gastrointestinal tract, gastric
metastasis from RCC is extremely rare, with only 19 cases reported
in the English literature.
The majority of gastric metastases from RCCs occurred among
male patients (72%), the average time of metastasis is approxi-
mately 7 years (ranged 0–20 years) for both genders (Table 1). In
contrast, the mean interval between the diagnosis of the primary
tumor other than RCC and the development of gastric metastasis
is 1.3 years.5 Thus, gastric metastasis seems to be a late event in
patients with RCC. An isolated gastric metastasis from RCC was
reported even 20 years after radical nephrectomy, suggesting RCC
has the potential for late solitary metastasis.6 On the other hand,
25–30% of patients with RCC had distant metastases at the time
of diagnosis.7 Thus, it is not surprising that our patient developed
gastric metastases 5 months after nephrectomy.
The presenting symptoms in patients with gastric metastasis
from RCC are mainly upper gastrointestinal bleeding (65%) and
iron deﬁciency anemia (35%) (Table 1). Gastric metastases are more
common in the body (63%), and are more likely to be large, soli-
tary mass or ulcer (average size of 4.8 cm)  resembling primary
gastric cancer endoscopically. The present patient had two  small
(0.6 cm)  gastric polyps, which were the smallest documented gas-
tric metastases from RCC. The endoscopic ﬁndings of these two
gastric polyps were benign-appearing, similar to her colonic polyps.
Thus, a careful endoscopic examination is crucial for identiﬁca-
tion of early metastasis. Further, any unusual histological ﬁndings
should prompt the pathologist to perform necessary ancillary stud-
ies to conﬁrm/rule out metastasis.
Histologically, metastatic RCC are predominantly clear cell type
(Table 1). Thus, the presence of clear cell morphology in any
unknown lesion should prompt the pathologist to exclude the pos-
sibility of metastatic RCC, even in the absence of a prior diagnosis.
Immunohistochemistry is a useful tool in this setting, especially
vimentin and PAX-2. Vimentin is an intermediate ﬁlament protein
expressed in normal renal tissues and in 87% of clear cell RCCs.8
PAX-2, a transcription factor required for development and prolif-
eration of renal tubules, is expressed in 85% of metastatic clear cell
RCCs.9
The management modalities for gastric metastasis from RCC
include total or subtotal gastrectomy, endoscopic resection,
embolization of the metastasis, chemotherapy, and immunother-
apy (Table 1). The optimal treatment for gastric metastases from
RCC remains controversial. In the absence of diffuse disease, aggres-
sive therapy including surgical resection is appropriate for isolated
gastric metastasis. In patients with gastrointestinal bleeding, sur-
gical excision of gastric metastasis may  be essential to prevent
rebleeding.
4. Conclusion
The present case exempliﬁes that gastric metastases from RCC
can be subtle and present as multiple, small benign-appearing
polyps. This case also highlights the importance of a careful
endoscopic examination as well as a thorough histopathologic
examination in patients with a history of RCC who  present with
gastrointestinal manifestations, as minute and unexpected ﬁndings
can directly impact patient care.Conﬂict of interest statement
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